KORU Medical Systems, Inc. (KRMD) 10-Year Financial Performance & Capital Metrics

KRMD • • Industrial / General

HealthcareMedical InstrumentsInfusion & Drug Delivery SystemsInfusion Pumps & Systems

AboutKORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.Show more

Revenue $34M +18.0%
EBITDA -$6M +39.6%
Net Income -$6M +55.9%
EPS (Diluted) -0.13 +56.7%
Gross Margin 63.4% +8.2%
EBITDA Margin -16.86% +48.8%
Operating Margin -19.16% +46.8%
Net Margin -18.03% +62.6%
ROE -32.64% +38.6%
ROIC -39.4% +17.7%
Debt/Equity 0.24 +8.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 91 (top 9%)
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Expensive at 15.4x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y11.58%

5Y7.75%

3Y12.72%

TTM22.12%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM68.99%

EPS CAGR

10Y-

5Y-

3Y-

TTM66.96%

ROCE

10Y Avg-7.16%

5Y Avg-23.69%

3Y Avg-31.29%

Latest-29.29%

Peer Comparison

Infusion Pumps & Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
INFUInfuSystem Holdings, Inc.	174.89M	8.60	78.18	7.22%	3.92%	9.96%	1.5%	0.49
BAXBaxter International Inc.	10.47B	20.37	-16.04	2.66%	-3.09%	-4.73%	5.34%	1.91
KRMDKORU Medical Systems, Inc.	262.65M	5.67	-43.62	17.98%	-9.5%	-22.55%		0.24

Profit & Loss

	Feb 2016	Feb 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	12.25M	12.29M	15.98M	17.35M	23.16M	24.18M	23.49M	27.9M	28.52M	33.65M
Revenue Growth %	0.09%	0%	0.3%	0.09%	0.33%	0.04%	-0.03%	0.19%	0.02%	0.18%
Cost of Goods Sold+	4.64M	4.72M	6.52M	6.54M	8.31M	9.24M	9.72M	12.53M	11.81M	12.31M
COGS % of Revenue	0.38%	0.38%	0.41%	0.38%	0.36%	0.38%	0.41%	0.45%	0.41%	0.37%
Gross Profit+	7.6M	7.57M	9.46M	10.81M	14.85M	14.94M	13.77M	15.37M	16.71M	21.33M
Gross Margin %	0.62%	0.62%	0.59%	0.62%	0.64%	0.62%	0.59%	0.55%	0.59%	0.63%
Gross Profit Growth %	0.14%	-0%	0.25%	0.14%	0.37%	0.01%	-0.08%	0.12%	0.09%	0.28%
Operating Expenses+	6.42M	8.31M	7.97M	8.75M	10.85M	16.19M	20.8M	26.15M	26.98M	27.78M
OpEx % of Revenue	0.52%	0.68%	0.5%	0.5%	0.47%	0.67%	0.89%	0.94%	0.95%	0.83%
Selling, General & Admin	5.94M	7.77M	7.91M	8.2M	9.77M	0	0	0	0	0
SG&A % of Revenue	0.49%	0.63%	0.5%	0.47%	0.42%	-	-	-	-	-
Research & Development	207.28K	237.49K	60.7K	241.12K	740.48K	1.3M	2.47M	4.96M	5.74M	5.26M
R&D % of Revenue	0.02%	0.02%	0%	0.01%	0.03%	0.05%	0.11%	0.18%	0.2%	0.16%
Other Operating Expenses	-9.2K	0	0	0	0	14.89M	18.33M	21.19M	21.24M	22.52M
Operating Income+	1.18M	-736.25K	1.48M	1.16M	585.68K	-1.25M	-7.03M	-10.78M	-10.27M	-6.45M
Operating Margin %	0.1%	-0.06%	0.09%	0.07%	0.03%	-0.05%	-0.3%	-0.39%	-0.36%	-0.19%
Operating Income Growth %	0.03%	-1.62%	3.02%	-0.22%	-0.5%	-3.14%	-4.6%	-0.53%	0.05%	0.37%
EBITDA+	1.45M	-435.64K	1.79M	1.47M	925.91K	-836.19K	-6.57M	-10.19M	-9.4M	-5.67M
EBITDA Margin %	0.12%	-0.04%	0.11%	0.08%	0.04%	-0.03%	-0.28%	-0.37%	-0.33%	-0.17%
EBITDA Growth %	0.02%	-1.3%	5.11%	-0.18%	-0.37%	-1.9%	-6.85%	-0.55%	0.08%	0.4%
D&A (Non-Cash Add-back)	271.57K	300.61K	308.71K	309.26K	340.23K	418.6K	463.13K	587.14K	870.39K	772.89K
EBIT	1.15M	-774.81K	1.48M	2.06M	4M	1.19M	-7.03M	-10.78M	-10.27M	-6.45M
Net Interest Income+	-3.41K	1.05K	0	28.1K	80.66K	42.4K	13.08K	145.59K	561.33K	444.64K
Interest Income	0	2.94K	0	28.1K	80.66K	42.4K	13.08K	145.59K	561.33K	444.64K
Interest Expense	3.41K	1.89K	0	0	0	0	0	0	0	0
Other Income/Expense	-38.81K	-40.45K	85.18K	12.41K	110.74K	60.52K	665.09K	105.71K	496.4K	382.49K
Pretax Income+	1.14M	-776.7K	1.57M	1.18M	696.42K	-1.19M	-6.36M	-10.68M	-9.77M	-6.06M
Pretax Margin %	0.09%	-0.06%	0.1%	0.07%	0.03%	-0.05%	-0.27%	-0.38%	-0.34%	-0.18%
Income Tax+	359.71K	-241.7K	483.07K	266.38K	132.07K	17.8K	-1.8M	-2.01M	3.97M	2.89K
Effective Tax Rate %	0.69%	0.69%	0.69%	0.77%	0.81%	1.01%	0.72%	0.81%	1.41%	1%
Net Income+	782.86K	-535K	1.09M	910.57K	564.35K	-1.21M	-4.56M	-8.66M	-13.74M	-6.07M
Net Margin %	0.06%	-0.04%	0.07%	0.05%	0.02%	-0.05%	-0.19%	-0.31%	-0.48%	-0.18%
Net Income Growth %	0.04%	-1.68%	3.03%	-0.16%	-0.38%	-3.15%	-2.76%	-0.9%	-0.59%	0.56%
Net Income (Continuing)	782.86K	-535K	1.09M	910.57K	564.35K	-1.21M	-4.56M	-8.66M	-13.74M	-6.07M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.02	-0.01	0.03	0.02	0.01	-0.03	-0.10	-0.19	-0.30	-0.13
EPS Growth %	0%	-1.71%	3.01%	-0.17%	-0.38%	-3.01%	-2.46%	-0.9%	-0.58%	0.57%
EPS (Basic)	0.02	-0.01	0.03	0.02	0.01	-0.03	-0.10	-0.19	-0.30	-0.13
Diluted Shares Outstanding	37.99M	37.88M	38.39M	38.92M	39.06M	41.93M	44.39M	45M	45.6M	45.8M
Basic Shares Outstanding	37.99M	37.83M	37.87M	38.13M	38.78M	41.93M	44.39M	45M	45.6M	45.8M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Feb 2016	Feb 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	6.91M	6.78M	7.93M	9.03M	11.88M	37.53M	37.32M	29.8M	20.26M	19.13M
Cash & Short-Term Investments	3.6M	3.58M	4.24M	3.74M	5.87M	27.32M	25.33M	17.41M	11.48M	9.58M
Cash Only	3.34M	3.31M	3.97M	3.74M	5.87M	27.32M	25.33M	17.41M	11.48M	9.58M
Short-Term Investments	259.79K	262.31K	263.27K	0	0	0	0	0	0	0
Accounts Receivable	1.76M	1.67M	1.86M	1.43M	3.23M	2.57M	3.59M	3.56M	4.05M	6M
Days Sales Outstanding	52.39	49.72	42.54	29.99	50.97	38.84	55.83	46.57	51.77	65.07
Inventory	1.26M	1.35M	1.66M	2.1M	2.39M	6.83M	6.11M	6.4M	3.48M	2.8M
Days Inventory Outstanding	98.93	104.59	92.87	117.36	104.92	269.78	229.29	186.62	107.6	83.1
Other Current Assets	0	0	0	1.52M	0	0	718.22K	972.4K	28.89K	749.85K
Total Non-Current Assets+	1.29M	1.39M	1.35M	1.51M	2M	2.39M	3.97M	12.53M	8.21M	8.09M
Property, Plant & Equipment	1.05M	932.09K	836.28K	858.78K	985.58K	1.4M	1.2M	7.67M	7.35M	7.26M
Fixed Asset Turnover	11.71x	13.19x	19.10x	20.21x	23.50x	17.21x	19.54x	3.64x	3.88x	4.64x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	210.26K	426.94K	483.82K	632.16K	807.13K	843.59K	808.81K	787.18K	754.36K	730.28K
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	31.14K	31.49K	31.58K	19.58K	19.58K	145.09K	1.96M	4.07M	98.97K	98.97K
Total Assets+	8.19M	8.17M	9.28M	10.55M	13.88M	39.92M	41.29M	42.33M	28.46M	27.22M
Asset Turnover	1.49x	1.50x	1.72x	1.65x	1.67x	0.61x	0.57x	0.66x	1.00x	1.24x
Asset Growth %	0.13%	-0%	0.14%	0.14%	0.32%	1.88%	0.03%	0.03%	-0.33%	-0.04%
Total Current Liabilities+	1.14M	1.39M	1.59M	1.58M	2.41M	3.67M	4.79M	6.96M	4.45M	7.2M
Accounts Payable	522.34K	772.43K	454.4K	453.5K	572.66K	624.92K	1.23M	2.39M	975.19K	1.65M
Days Payables Outstanding	41.05	59.68	25.44	25.3	25.16	24.68	46.09	69.69	30.14	48.9
Short-Term Debt	0	0	0	0	142.18K	0	508.58K	433.3K	314.34K	271.15K
Deferred Revenue (Current)	22.48K	22.48K	0	3.76K	0	0	0	0	0	0
Other Current Liabilities	434.12K	0	796.39K	688.65K	1.36M	0	90K	257.34K	512.52K	29.27K
Current Ratio	6.06x	4.88x	5.00x	5.70x	4.94x	10.24x	7.79x	4.28x	4.55x	2.66x
Quick Ratio	4.95x	3.91x	3.95x	4.37x	3.95x	8.37x	6.51x	3.36x	3.77x	2.27x
Cash Conversion Cycle	110.27	94.63	109.97	122.05	130.74	283.94	239.02	163.49	129.23	99.26
Total Non-Current Liabilities+	282.14K	104.92K	25.44K	0	239.49K	95.55K	0	4.05M	3.65M	3.2M
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	239.49K	95.55K	0	4.05M	3.65M	3.2M
Deferred Tax Liabilities	231.54K	82.42K	21.68K	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	3.76K	0	0	0	0	1	0	0
Total Liabilities	1.42M	1.49M	1.61M	1.58M	2.65M	3.76M	4.79M	11.01M	8.11M	10.4M
Total Debt+	0	0	0	0	381.68K	239.49K	604.14K	4.93M	4.45M	3.99M
Net Debt	-3.34M	-3.31M	-3.97M	-3.74M	-5.49M	-27.08M	-24.73M	-12.48M	-7.04M	-5.59M
Debt / Equity	-	-	-	-	0.03x	0.01x	0.02x	0.16x	0.22x	0.24x
Debt / EBITDA	-	-	-	-	0.41x	-	-	-	-	-
Net Debt / EBITDA	-2.30x	-	-2.22x	-2.54x	-5.93x	-	-	-	-	-
Interest Coverage	346.24x	-390.38x	-	-	-	-	-	-	-	-
Total Equity+	6.77M	6.68M	7.67M	8.96M	11.24M	36.16M	36.5M	31.33M	20.35M	16.81M
Equity Growth %	0.08%	-0.01%	0.15%	0.17%	0.25%	2.22%	0.01%	-0.14%	-0.35%	-0.17%
Book Value per Share	0.18	0.18	0.20	0.23	0.29	0.86	0.82	0.70	0.45	0.37
Total Shareholders' Equity	6.77M	6.68M	7.67M	8.96M	11.24M	36.16M	36.5M	31.33M	20.35M	16.81M
Common Stock	403.47K	405.58K	407.31K	409.33K	422.4K	466.8K	480.44K	488.62K	490.9K	493.78K
Retained Earnings	2.68M	2.48M	3.39M	4.3M	4.86M	3.65M	-910.07K	-9.57M	-23.31M	-29.38M
Treasury Stock	-166.28K	-344.2K	-344.2K	-344.2K	-344.2K	-3.84M	-3.84M	-3.84M	-3.84M	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Feb 2016	Feb 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.91M	-331.62K	899.91K	1.48M	320.62K	-743.32K	-4.32M	-5.4M	-4.89M	-319.72K
Operating CF Margin %	0.16%	-0.03%	0.06%	0.09%	0.01%	-0.03%	-0.18%	-0.19%	-0.17%	-0.01%
Operating CF Growth %	1.32%	-1.17%	3.71%	0.64%	-0.78%	-3.32%	-4.81%	-0.25%	0.09%	0.93%
Net Income	782.86K	-535K	1.09M	910.57K	564.35K	-1.21M	-4.56M	-8.66M	-13.74M	-6.07M
Depreciation & Amortization	271.57K	300.61K	308.71K	309.26K	340.23K	418.6K	463.13K	587.14K	870.39K	888.47K
Stock-Based Compensation	114.56K	205.49K	129.7K	366.08K	1.2M	1.62M	2.71M	3.08M	2.77M	2.62M
Deferred Taxes	-125.5K	-40.69K	-60.75K	-23.14K	-186.78K	62.97K	-1.82M	-2.03M	3.97M	0
Other Non-Cash Items	6.71K	-13.84K	1.58M	-66.98K	-56.45K	1.3M	-1.01K	212.55K	37.82K	934.33K
Working Capital Changes	864.61K	-248.19K	-349.85K	-16.13K	-1.55M	-2.93M	-1.11M	1.4M	1.2M	1.3M
Change in Receivables	286.43K	-132.49K	-418.86K	475.66K	-1.8M	669.74K	-1.74M	-220.17K	457.18K	-1.68M
Change in Inventory	186.36K	-313.43K	-304.98K	-445.2K	-284.6K	-4.44M	723.43K	-298.53K	2.92M	677.63K
Change in Payables	64.55K	464.66K	-318.03K	-900	119.16K	52.26K	602.61K	1.16M	-1.42M	0
Cash from Investing+	-189.52K	-416.33K	-219.28K	-1.73M	1.31M	-1.04M	-366.17K	-2.8M	-814.6K	-1.33M
Capital Expenditures	-201.74K	-415.13K	-218.33K	-481.17K	-425.54K	-920.6K	-346.18K	-2.76M	-782.95K	-1.3M
CapEx % of Revenue	0.02%	0.03%	0.01%	0.03%	0.02%	0.04%	0.01%	0.1%	0.03%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-66.41K	-212.01K	-955	-475.17K	-6.54K	-115.55K	-19.99K	-40.51K	-31.65K	-35.62K
Cash from Financing+	-80.58K	-140.74K	-19.36K	14.43K	501.3K	23.22M	2.71M	279.49K	-218.87K	-248.53K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	0	-36.82K	0	0	0	0	0	-43.19K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	1.71M	-746.75K	681.59K	998.5K	-104.92K	-1.8M	-4.69M	-8.21M	-5.71M	-1.62M
FCF Margin %	0.14%	-0.06%	0.04%	0.06%	-0%	-0.07%	-0.2%	-0.29%	-0.2%	-0.05%
FCF Growth %	19.81%	-1.44%	1.91%	0.46%	-1.11%	-16.2%	-1.6%	-0.75%	0.3%	0.72%
FCF per Share	0.05	-0.02	0.02	0.03	-0.00	-0.04	-0.11	-0.18	-0.13	-0.04
FCF Conversion (FCF/Net Income)	2.45x	0.62x	0.83x	1.62x	0.57x	0.61x	0.95x	0.62x	0.36x	0.05x
Interest Paid	3.41K	1.89K	0	0	342	27.74K	13.24K	28.49K	50.83K	71.93K
Taxes Paid	255K	194.47K	0	378K	130.88K	321.98K	1.9K	0	3.16K	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	12%	-7.96%	15.14%	10.95%	5.59%	-5.11%	-12.56%	-25.54%	-53.18%	-32.64%
Return on Invested Capital (ROIC)	24.79%	-16.25%	31.54%	19.59%	8.01%	-12.69%	-50.57%	-52.83%	-47.9%	-39.4%
Gross Margin	62.08%	61.57%	59.2%	62.29%	64.13%	61.78%	58.62%	55.09%	58.59%	63.4%
Net Margin	6.39%	-4.35%	6.8%	5.25%	2.44%	-5.01%	-19.42%	-31.05%	-48.18%	-18.03%
Debt / Equity	-	-	-	-	0.03x	0.01x	0.02x	0.16x	0.22x	0.24x
Interest Coverage	346.24x	-390.38x	-	-	-	-	-	-	-	-
FCF Conversion	2.45x	0.62x	0.83x	1.62x	0.57x	0.61x	0.95x	0.62x	0.36x	0.05x
Revenue Growth	8.92%	0.38%	29.96%	8.62%	33.47%	4.38%	-2.84%	18.76%	2.23%	17.98%

Frequently Asked Questions

Growth & Financials

KORU Medical Systems, Inc. (KRMD) reported $39.1M in revenue for fiscal year 2024. This represents a 511% increase from $6.4M in 2011.

KORU Medical Systems, Inc. (KRMD) grew revenue by 18.0% over the past year. This is strong growth.

KORU Medical Systems, Inc. (KRMD) reported a net loss of $3.7M for fiscal year 2024.

Dividend & Returns

KORU Medical Systems, Inc. (KRMD) has a return on equity (ROE) of -32.6%. Negative ROE indicates the company is unprofitable.

KORU Medical Systems, Inc. (KRMD) had negative free cash flow of $0.2M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

KORU Medical Systems, Inc. (KRMD) 10-Year Financial Performance & Capital Metrics

KRMD • • Industrial / General

HealthcareMedical InstrumentsInfusion & Drug Delivery SystemsInfusion Pumps & Systems

Revenue $34M +18.0%
EBITDA -$6M +39.6%
Net Income -$6M +55.9%
EPS (Diluted) -0.13 +56.7%
Gross Margin 63.4% +8.2%
EBITDA Margin -16.86% +48.8%
Operating Margin -19.16% +46.8%
Net Margin -18.03% +62.6%
ROE -32.64% +38.6%
ROIC -39.4% +17.7%
Debt/Equity 0.24 +8.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 91 (top 9%)
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Expensive at 15.4x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y11.58%

5Y7.75%

3Y12.72%

TTM22.12%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM68.99%

EPS CAGR

10Y-

5Y-

3Y-

TTM66.96%

ROCE

10Y Avg-7.16%

5Y Avg-23.69%

3Y Avg-31.29%

Latest-29.29%

Peer Comparison

Infusion Pumps & Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
INFUInfuSystem Holdings, Inc.	174.89M	8.60	78.18	7.22%	3.92%	9.96%	1.5%	0.49
BAXBaxter International Inc.	10.47B	20.37	-16.04	2.66%	-3.09%	-4.73%	5.34%	1.91
KRMDKORU Medical Systems, Inc.	262.65M	5.67	-43.62	17.98%	-9.5%	-22.55%		0.24

Profit & Loss

	Feb 2016	Feb 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	12.25M	12.29M	15.98M	17.35M	23.16M	24.18M	23.49M	27.9M	28.52M	33.65M
Revenue Growth %	0.09%	0%	0.3%	0.09%	0.33%	0.04%	-0.03%	0.19%	0.02%	0.18%
Cost of Goods Sold+	4.64M	4.72M	6.52M	6.54M	8.31M	9.24M	9.72M	12.53M	11.81M	12.31M
COGS % of Revenue	0.38%	0.38%	0.41%	0.38%	0.36%	0.38%	0.41%	0.45%	0.41%	0.37%
Gross Profit+	7.6M	7.57M	9.46M	10.81M	14.85M	14.94M	13.77M	15.37M	16.71M	21.33M
Gross Margin %	0.62%	0.62%	0.59%	0.62%	0.64%	0.62%	0.59%	0.55%	0.59%	0.63%
Gross Profit Growth %	0.14%	-0%	0.25%	0.14%	0.37%	0.01%	-0.08%	0.12%	0.09%	0.28%
Operating Expenses+	6.42M	8.31M	7.97M	8.75M	10.85M	16.19M	20.8M	26.15M	26.98M	27.78M
OpEx % of Revenue	0.52%	0.68%	0.5%	0.5%	0.47%	0.67%	0.89%	0.94%	0.95%	0.83%
Selling, General & Admin	5.94M	7.77M	7.91M	8.2M	9.77M	0	0	0	0	0
SG&A % of Revenue	0.49%	0.63%	0.5%	0.47%	0.42%	-	-	-	-	-
Research & Development	207.28K	237.49K	60.7K	241.12K	740.48K	1.3M	2.47M	4.96M	5.74M	5.26M
R&D % of Revenue	0.02%	0.02%	0%	0.01%	0.03%	0.05%	0.11%	0.18%	0.2%	0.16%
Other Operating Expenses	-9.2K	0	0	0	0	14.89M	18.33M	21.19M	21.24M	22.52M
Operating Income+	1.18M	-736.25K	1.48M	1.16M	585.68K	-1.25M	-7.03M	-10.78M	-10.27M	-6.45M
Operating Margin %	0.1%	-0.06%	0.09%	0.07%	0.03%	-0.05%	-0.3%	-0.39%	-0.36%	-0.19%
Operating Income Growth %	0.03%	-1.62%	3.02%	-0.22%	-0.5%	-3.14%	-4.6%	-0.53%	0.05%	0.37%
EBITDA+	1.45M	-435.64K	1.79M	1.47M	925.91K	-836.19K	-6.57M	-10.19M	-9.4M	-5.67M
EBITDA Margin %	0.12%	-0.04%	0.11%	0.08%	0.04%	-0.03%	-0.28%	-0.37%	-0.33%	-0.17%
EBITDA Growth %	0.02%	-1.3%	5.11%	-0.18%	-0.37%	-1.9%	-6.85%	-0.55%	0.08%	0.4%
D&A (Non-Cash Add-back)	271.57K	300.61K	308.71K	309.26K	340.23K	418.6K	463.13K	587.14K	870.39K	772.89K
EBIT	1.15M	-774.81K	1.48M	2.06M	4M	1.19M	-7.03M	-10.78M	-10.27M	-6.45M
Net Interest Income+	-3.41K	1.05K	0	28.1K	80.66K	42.4K	13.08K	145.59K	561.33K	444.64K
Interest Income	0	2.94K	0	28.1K	80.66K	42.4K	13.08K	145.59K	561.33K	444.64K
Interest Expense	3.41K	1.89K	0	0	0	0	0	0	0	0
Other Income/Expense	-38.81K	-40.45K	85.18K	12.41K	110.74K	60.52K	665.09K	105.71K	496.4K	382.49K
Pretax Income+	1.14M	-776.7K	1.57M	1.18M	696.42K	-1.19M	-6.36M	-10.68M	-9.77M	-6.06M
Pretax Margin %	0.09%	-0.06%	0.1%	0.07%	0.03%	-0.05%	-0.27%	-0.38%	-0.34%	-0.18%
Income Tax+	359.71K	-241.7K	483.07K	266.38K	132.07K	17.8K	-1.8M	-2.01M	3.97M	2.89K
Effective Tax Rate %	0.69%	0.69%	0.69%	0.77%	0.81%	1.01%	0.72%	0.81%	1.41%	1%
Net Income+	782.86K	-535K	1.09M	910.57K	564.35K	-1.21M	-4.56M	-8.66M	-13.74M	-6.07M
Net Margin %	0.06%	-0.04%	0.07%	0.05%	0.02%	-0.05%	-0.19%	-0.31%	-0.48%	-0.18%
Net Income Growth %	0.04%	-1.68%	3.03%	-0.16%	-0.38%	-3.15%	-2.76%	-0.9%	-0.59%	0.56%
Net Income (Continuing)	782.86K	-535K	1.09M	910.57K	564.35K	-1.21M	-4.56M	-8.66M	-13.74M	-6.07M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.02	-0.01	0.03	0.02	0.01	-0.03	-0.10	-0.19	-0.30	-0.13
EPS Growth %	0%	-1.71%	3.01%	-0.17%	-0.38%	-3.01%	-2.46%	-0.9%	-0.58%	0.57%
EPS (Basic)	0.02	-0.01	0.03	0.02	0.01	-0.03	-0.10	-0.19	-0.30	-0.13
Diluted Shares Outstanding	37.99M	37.88M	38.39M	38.92M	39.06M	41.93M	44.39M	45M	45.6M	45.8M
Basic Shares Outstanding	37.99M	37.83M	37.87M	38.13M	38.78M	41.93M	44.39M	45M	45.6M	45.8M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Feb 2016	Feb 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	6.91M	6.78M	7.93M	9.03M	11.88M	37.53M	37.32M	29.8M	20.26M	19.13M
Cash & Short-Term Investments	3.6M	3.58M	4.24M	3.74M	5.87M	27.32M	25.33M	17.41M	11.48M	9.58M
Cash Only	3.34M	3.31M	3.97M	3.74M	5.87M	27.32M	25.33M	17.41M	11.48M	9.58M
Short-Term Investments	259.79K	262.31K	263.27K	0	0	0	0	0	0	0
Accounts Receivable	1.76M	1.67M	1.86M	1.43M	3.23M	2.57M	3.59M	3.56M	4.05M	6M
Days Sales Outstanding	52.39	49.72	42.54	29.99	50.97	38.84	55.83	46.57	51.77	65.07
Inventory	1.26M	1.35M	1.66M	2.1M	2.39M	6.83M	6.11M	6.4M	3.48M	2.8M
Days Inventory Outstanding	98.93	104.59	92.87	117.36	104.92	269.78	229.29	186.62	107.6	83.1
Other Current Assets	0	0	0	1.52M	0	0	718.22K	972.4K	28.89K	749.85K
Total Non-Current Assets+	1.29M	1.39M	1.35M	1.51M	2M	2.39M	3.97M	12.53M	8.21M	8.09M
Property, Plant & Equipment	1.05M	932.09K	836.28K	858.78K	985.58K	1.4M	1.2M	7.67M	7.35M	7.26M
Fixed Asset Turnover	11.71x	13.19x	19.10x	20.21x	23.50x	17.21x	19.54x	3.64x	3.88x	4.64x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	210.26K	426.94K	483.82K	632.16K	807.13K	843.59K	808.81K	787.18K	754.36K	730.28K
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	31.14K	31.49K	31.58K	19.58K	19.58K	145.09K	1.96M	4.07M	98.97K	98.97K
Total Assets+	8.19M	8.17M	9.28M	10.55M	13.88M	39.92M	41.29M	42.33M	28.46M	27.22M
Asset Turnover	1.49x	1.50x	1.72x	1.65x	1.67x	0.61x	0.57x	0.66x	1.00x	1.24x
Asset Growth %	0.13%	-0%	0.14%	0.14%	0.32%	1.88%	0.03%	0.03%	-0.33%	-0.04%
Total Current Liabilities+	1.14M	1.39M	1.59M	1.58M	2.41M	3.67M	4.79M	6.96M	4.45M	7.2M
Accounts Payable	522.34K	772.43K	454.4K	453.5K	572.66K	624.92K	1.23M	2.39M	975.19K	1.65M
Days Payables Outstanding	41.05	59.68	25.44	25.3	25.16	24.68	46.09	69.69	30.14	48.9
Short-Term Debt	0	0	0	0	142.18K	0	508.58K	433.3K	314.34K	271.15K
Deferred Revenue (Current)	22.48K	22.48K	0	3.76K	0	0	0	0	0	0
Other Current Liabilities	434.12K	0	796.39K	688.65K	1.36M	0	90K	257.34K	512.52K	29.27K
Current Ratio	6.06x	4.88x	5.00x	5.70x	4.94x	10.24x	7.79x	4.28x	4.55x	2.66x
Quick Ratio	4.95x	3.91x	3.95x	4.37x	3.95x	8.37x	6.51x	3.36x	3.77x	2.27x
Cash Conversion Cycle	110.27	94.63	109.97	122.05	130.74	283.94	239.02	163.49	129.23	99.26
Total Non-Current Liabilities+	282.14K	104.92K	25.44K	0	239.49K	95.55K	0	4.05M	3.65M	3.2M
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	239.49K	95.55K	0	4.05M	3.65M	3.2M
Deferred Tax Liabilities	231.54K	82.42K	21.68K	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	3.76K	0	0	0	0	1	0	0
Total Liabilities	1.42M	1.49M	1.61M	1.58M	2.65M	3.76M	4.79M	11.01M	8.11M	10.4M
Total Debt+	0	0	0	0	381.68K	239.49K	604.14K	4.93M	4.45M	3.99M
Net Debt	-3.34M	-3.31M	-3.97M	-3.74M	-5.49M	-27.08M	-24.73M	-12.48M	-7.04M	-5.59M
Debt / Equity	-	-	-	-	0.03x	0.01x	0.02x	0.16x	0.22x	0.24x
Debt / EBITDA	-	-	-	-	0.41x	-	-	-	-	-
Net Debt / EBITDA	-2.30x	-	-2.22x	-2.54x	-5.93x	-	-	-	-	-
Interest Coverage	346.24x	-390.38x	-	-	-	-	-	-	-	-
Total Equity+	6.77M	6.68M	7.67M	8.96M	11.24M	36.16M	36.5M	31.33M	20.35M	16.81M
Equity Growth %	0.08%	-0.01%	0.15%	0.17%	0.25%	2.22%	0.01%	-0.14%	-0.35%	-0.17%
Book Value per Share	0.18	0.18	0.20	0.23	0.29	0.86	0.82	0.70	0.45	0.37
Total Shareholders' Equity	6.77M	6.68M	7.67M	8.96M	11.24M	36.16M	36.5M	31.33M	20.35M	16.81M
Common Stock	403.47K	405.58K	407.31K	409.33K	422.4K	466.8K	480.44K	488.62K	490.9K	493.78K
Retained Earnings	2.68M	2.48M	3.39M	4.3M	4.86M	3.65M	-910.07K	-9.57M	-23.31M	-29.38M
Treasury Stock	-166.28K	-344.2K	-344.2K	-344.2K	-344.2K	-3.84M	-3.84M	-3.84M	-3.84M	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Feb 2016	Feb 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.91M	-331.62K	899.91K	1.48M	320.62K	-743.32K	-4.32M	-5.4M	-4.89M	-319.72K
Operating CF Margin %	0.16%	-0.03%	0.06%	0.09%	0.01%	-0.03%	-0.18%	-0.19%	-0.17%	-0.01%
Operating CF Growth %	1.32%	-1.17%	3.71%	0.64%	-0.78%	-3.32%	-4.81%	-0.25%	0.09%	0.93%
Net Income	782.86K	-535K	1.09M	910.57K	564.35K	-1.21M	-4.56M	-8.66M	-13.74M	-6.07M
Depreciation & Amortization	271.57K	300.61K	308.71K	309.26K	340.23K	418.6K	463.13K	587.14K	870.39K	888.47K
Stock-Based Compensation	114.56K	205.49K	129.7K	366.08K	1.2M	1.62M	2.71M	3.08M	2.77M	2.62M
Deferred Taxes	-125.5K	-40.69K	-60.75K	-23.14K	-186.78K	62.97K	-1.82M	-2.03M	3.97M	0
Other Non-Cash Items	6.71K	-13.84K	1.58M	-66.98K	-56.45K	1.3M	-1.01K	212.55K	37.82K	934.33K
Working Capital Changes	864.61K	-248.19K	-349.85K	-16.13K	-1.55M	-2.93M	-1.11M	1.4M	1.2M	1.3M
Change in Receivables	286.43K	-132.49K	-418.86K	475.66K	-1.8M	669.74K	-1.74M	-220.17K	457.18K	-1.68M
Change in Inventory	186.36K	-313.43K	-304.98K	-445.2K	-284.6K	-4.44M	723.43K	-298.53K	2.92M	677.63K
Change in Payables	64.55K	464.66K	-318.03K	-900	119.16K	52.26K	602.61K	1.16M	-1.42M	0
Cash from Investing+	-189.52K	-416.33K	-219.28K	-1.73M	1.31M	-1.04M	-366.17K	-2.8M	-814.6K	-1.33M
Capital Expenditures	-201.74K	-415.13K	-218.33K	-481.17K	-425.54K	-920.6K	-346.18K	-2.76M	-782.95K	-1.3M
CapEx % of Revenue	0.02%	0.03%	0.01%	0.03%	0.02%	0.04%	0.01%	0.1%	0.03%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-66.41K	-212.01K	-955	-475.17K	-6.54K	-115.55K	-19.99K	-40.51K	-31.65K	-35.62K
Cash from Financing+	-80.58K	-140.74K	-19.36K	14.43K	501.3K	23.22M	2.71M	279.49K	-218.87K	-248.53K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	0	-36.82K	0	0	0	0	0	-43.19K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	1.71M	-746.75K	681.59K	998.5K	-104.92K	-1.8M	-4.69M	-8.21M	-5.71M	-1.62M
FCF Margin %	0.14%	-0.06%	0.04%	0.06%	-0%	-0.07%	-0.2%	-0.29%	-0.2%	-0.05%
FCF Growth %	19.81%	-1.44%	1.91%	0.46%	-1.11%	-16.2%	-1.6%	-0.75%	0.3%	0.72%
FCF per Share	0.05	-0.02	0.02	0.03	-0.00	-0.04	-0.11	-0.18	-0.13	-0.04
FCF Conversion (FCF/Net Income)	2.45x	0.62x	0.83x	1.62x	0.57x	0.61x	0.95x	0.62x	0.36x	0.05x
Interest Paid	3.41K	1.89K	0	0	342	27.74K	13.24K	28.49K	50.83K	71.93K
Taxes Paid	255K	194.47K	0	378K	130.88K	321.98K	1.9K	0	3.16K	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	12%	-7.96%	15.14%	10.95%	5.59%	-5.11%	-12.56%	-25.54%	-53.18%	-32.64%
Return on Invested Capital (ROIC)	24.79%	-16.25%	31.54%	19.59%	8.01%	-12.69%	-50.57%	-52.83%	-47.9%	-39.4%
Gross Margin	62.08%	61.57%	59.2%	62.29%	64.13%	61.78%	58.62%	55.09%	58.59%	63.4%
Net Margin	6.39%	-4.35%	6.8%	5.25%	2.44%	-5.01%	-19.42%	-31.05%	-48.18%	-18.03%
Debt / Equity	-	-	-	-	0.03x	0.01x	0.02x	0.16x	0.22x	0.24x
Interest Coverage	346.24x	-390.38x	-	-	-	-	-	-	-	-
FCF Conversion	2.45x	0.62x	0.83x	1.62x	0.57x	0.61x	0.95x	0.62x	0.36x	0.05x
Revenue Growth	8.92%	0.38%	29.96%	8.62%	33.47%	4.38%	-2.84%	18.76%	2.23%	17.98%

Frequently Asked Questions

Growth & Financials

KORU Medical Systems, Inc. (KRMD) reported $39.1M in revenue for fiscal year 2024. This represents a 511% increase from $6.4M in 2011.

KORU Medical Systems, Inc. (KRMD) grew revenue by 18.0% over the past year. This is strong growth.

KORU Medical Systems, Inc. (KRMD) reported a net loss of $3.7M for fiscal year 2024.

Dividend & Returns

KORU Medical Systems, Inc. (KRMD) has a return on equity (ROE) of -32.6%. Negative ROE indicates the company is unprofitable.

KORU Medical Systems, Inc. (KRMD) had negative free cash flow of $0.2M in fiscal year 2024, likely due to heavy capital investments.